Dogwood Therapeutics, Inc. Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
Dogwood Therapeutics, Inc. (DWTX) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of 0.20% for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2025-03-31
- Dogwood Therapeutics, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2023 was 0.20%, a 233.33% increase from fiscal 2022.
- Dogwood Therapeutics, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2022 was 0.06%, a 60.00% decline from fiscal 2021.
- Dogwood Therapeutics, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2021 was 0.15%, a 44.44% decline from fiscal 2020.
- Dogwood Therapeutics, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2020 was 0.27%.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month |
|---|---|
| 2023-12-31 | 0.20% 10-K · filed 2025-03-31 |
| 2022-12-31 | 0.06% 10-K/A · filed 2024-03-08 |
| 2021-12-31 | 0.15% 10-K · filed 2023-03-14 |
| 2020-12-31 | 0.27% 10-K · filed 2022-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |